Join
Live feed
·
PRReleasevia Quantisnow
AstraZeneca PLC logo
Amgen Inc. logo

Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA

ByQuantisnow·Wall Street's wire, on your screen.
AZN· AstraZeneca PLCAMGN· Amgen Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AZN (AstraZeneca PLC), AMGN (Amgen Inc.) and more on Quantisnow.